KI-Beratung Beta

Produktbild: Handbook of Tuberculosis
Band 2 - 12%

Handbook of Tuberculosis

Aus der Reihe Handbook of Tuberculosis
12% sparen

423,99 € UVP 483,20 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Coinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific of all researchers in the field.Divided into three clearly structured...

Beschreibung

Coinciding with the first TB therapies to enter clinical trials in 60 years, this is the most comprehensive account of the latest developments in clinical, therapeutic and basic research into the disease, presented by the most prolific of all researchers in the field.Divided into three clearly structured volumes, the first deals with molecular biology and biochemistry of the pathogen, including genetics and genomics, as well as drug design. The second volume covers cell biology, immunology and vaccine development, while the third is devoted to epidemiology and clinical approaches, including drug resistance, veterinary aspects and clinical field trials.With one new infection worldwide every second, this is an essential reference for bacteriologists, immunologists, pathologists and pathophysiologists, molecular and cell biologists, as well as those working in the pharmaceutical industry.

Rezension

"...Edited and written by the leading experts in the field [this three volume handbook] is the most comprehensive book on this topic available..." -Anticancer Research

Produktdetails

Einband

Set mit diversen Artikeln

Erscheinungsdatum

13.02.2008

Abbildungen

60

Herausgeber Stefan H. E. Kaufmann + weitere

Produktdetails

Einband

Set mit diversen Artikeln

Erscheinungsdatum

13.02.2008

Abbildungen

60

Herausgeber
Verlag Wiley-VCH
Seitenzahl

1350

Maße (L/B/H)

7,6/17/24 cm

Gewicht

2714 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-3-527-31683-0

Herstelleradresse

Wiley-VCH GmbH
product_safety@wiley.com
Wiley-VCH GmbH, Boschstrasse 12, DE-69469 Weinheim

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Handbook of Tuberculosis
  • VOLUME 1: MOLECULAR BIOLOGY AND BIOCHEMISTRYTuberculosis - Molecular Genetics and Biochemistry: IntroductionBiochemistry of the Cell WallGlycolipids and Polyketides of M. tuberculosisPhysiology of M. tuberculosisNutrient TransportIron Uptake by M. tuberculosisProtein TransportPE and PPE Gene Family Members in M. tuberculosisVirulence/Persistence Mechanisms of M. tuberculosisGenomicsTranscriptomics and Transcriptional RegulationProteomics of M. tuberculosisStructureMolecular Mechanisms of Dormancy and ResuscitationM. tuberculosis in the PhagosomeMolecular Mechanisms of Drug Resistance of M. tuberculosisExperimental Genetics of M. tuberculosisMolecular Evolution of MycobacteriaVOLUME 2: IMMUNOLOGY AND CELL BIOLOGYIntroduction: Immunity to M. tuberculosis and BCGRecognition Receptors and Phagocytosis for M. tuberculosisTranscriptional Response of Macrophages and Dendritic Cells to M. tuberculosisDendritic Cells and Antigen PresentationKilling Mechanisms of the Host Against M. tuberculosisManipulation of the Macrophage ResponseConventional T Cells and their Antigenic RepertoireUnconventional T CellsCytokines in TuberculosisAntibodies in TuberculosisPathologyMaintenance of Latent Infection with Correlates of Protective ImmunityGenetics of Resistance (mouse and man)HIV/TB InteractionsNovel Vaccination Strategies Against TuberculosisExperimental Animal Models of TuberculosisVOLUME 3: CLINICS DIAGNOSTICS THERAPY AND EPIDEMIOLOGYClinics Diagnostics Therapy Epidemiology: IntroductionGlobal Epidemiology of TuberculosisSurveillance Studies and InterpretationMolecular Epidemiology of M. tuberculosisDiagnosis of M. tuberculosis: ClinicalClinical Disease (with and without HIV)Management of Tuberculosis PatientsChemotherapyNew Drugs and Clinical Drug TrialsLatencyDrug Resistance in Clinical ContextNovel Drug Treatment Strategies - Co-infectionsModelingBCG Vaccination